Below is Alston & Bird’s
Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
Week in Review Highlight of the Week:
This week, CMS released its FY 2022 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Rates Proposed Rule. Read more about the rule and other news below.
I. Regulations, Notices & Guidance
On April 26, 2021, the Food and Drug Administration (FDA) issued guidance entitled,
Nonclinical Testing of Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating or Life-Threatening Diseases; Draft Guidance for Sponsor-Investigators. FDA is publishing this draft guidance to help sponsor-investigators with developing the nonclinical information that FDA recommends to support an investigational new drug application (IND) for certain individual
Share this article
Share this article
JERSEY CITY, N.J., April 20, 2021 /PRNewswire/ Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of an analysis of the timing of disease progression milestones among commercially insured amyotrophic lateral sclerosis (ALS) patients treated with intravenous (IV) RADICAVA
® (edaravone). The findings are being presented during the 2021 Virtual American Academy of Neurology (AAN) Annual Meeting, held April 17-22. We are pleased to share these data, which may provide information to the ALS community by observing the time to real-world milestones associated with ALS progression, said Gustavo A. Suarez Zambrano, M.D., Vice President of Medical Affairs, MTPA. The results from this new analysis of real-world data gives clinicians more information that may be useful in evaluating treatment for their patients.
HoCo Doctor To Reimburse Government $663K For Fraudulent Claims patch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from patch.com Daily Mail and Mail on Sunday newspapers.
Boost Operational, Clinical and Financial Performance with Good Data
by Pete Nelson, Vice President and General Manager, Global Alliances, GHX
Peter Nelson, VP & General Manager, Global Alliances at GHX
There’s an old adage that every challenge is merely an opportunity in disguise. COVID-19 highlighted the healthcare industry’s ongoing challenge with producing clean, standardized data. As the industry looks to rebound from the severe financial impact of the pandemic, there’s a renewed urgency among hospitals and health networks to improve operational efficiency.
The push toward greater operational efficiency – in a time of constrained budgets and resources – has accelerated healthcare’s move toward cloud ERP, a market expected to grow by more than $36 billion in the next five years. It’s important to note, however, that simply moving to the cloud will not bring the desired results unless hospitals first address their data issues. In an environment where every pe
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
RadioMedix & Curium Announce Permanent HCPCS Code for DetectnetTM (copper Cu 64 dotatate .
CuriumJanuary 26, 2021 GMT
St. Louis, MO, Jan. 26, 2021 (GLOBE NEWSWIRE) RadioMedix Inc. and its commercial partner Curium announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Detectnet a permanent Healthcare Common Procedure Coding System (HCPCS) code – A9592 – effective April 1, 2021. The descriptor for this product specific A code will be: Copper Cu-64, dotatate, diagnostic, 1 millicurie. Beginning on April 1, 2021, this code will be available to bill claims for Medicare patients in non-hospital imaging centers and for private insurance patients in all imaging facilities. This information follows the recent news that Detectnet was granted Transitional Pass-Through Status by CMS (C9068) effective January 1, 2021. C9068 is used to bill Detectnet for Med